These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3493442)
1. Use of second antibody in radioimmunotherapy. Begent RH; Bagshawe KD; Pedley RB; Searle F; Ledermann JA; Green AJ; Keep PA; Chester KA; Glaser MG; Dale RG NCI Monogr; 1987; (3):59-61. PubMed ID: 3493442 [TBL] [Abstract][Full Text] [Related]
2. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49. Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364 [TBL] [Abstract][Full Text] [Related]
3. Radioimmunotherapy of carcinoma of colon with [131I]-labeled recombinant chimeric monoclonal antibodies to carcinoembryonic antigen. Lu QJ; Bian GX; Chen YY; Zhang M; Guo SM; Wen LQ Acta Pharmacol Sin; 2005 Oct; 26(10):1259-64. PubMed ID: 16174444 [TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial. Behr TM; Memtsoudis S; Vougioukas V; Liersch T; Gratz S; Schmidt F; Lorf T; Post S; Wörmann B; Hiddemann W; Ringe B; Becker W Anticancer Res; 1999; 19(4A):2427-32. PubMed ID: 10470170 [TBL] [Abstract][Full Text] [Related]
5. Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody. Stein R; Govindan SV; Hayes M; Griffiths GL; Hansen HJ; Horak ID; Goldenberg DM Clin Cancer Res; 2005 Apr; 11(7):2727-34. PubMed ID: 15814655 [TBL] [Abstract][Full Text] [Related]
7. [Influence of combination of low dosage 131I-labeled anti-carcinoembryonic antigen antibody C50 and 5-fluorouracil on tumor growth of colorectal cancer xenografts in nude mice]. Zheng CX; Zhan WH; Cai SR; He YL; Lin ZJ Ai Zheng; 2003 Apr; 22(4):354-7. PubMed ID: 12703987 [TBL] [Abstract][Full Text] [Related]
8. Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody. Gautherot E; Kraeber-Bodéré F; Daniel L; Fiche M; Rouvier E; Saï-Maurel C; Thedrez P; Chatal JF; Barbet J Clin Cancer Res; 1999 Oct; 5(10 Suppl):3177s-3182s. PubMed ID: 10541361 [TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen. Sharkey RM; Kaltovich FA; Shih LB; Fand I; Govelitz G; Goldenberg DM Cancer Res; 1988 Jun; 48(11):3270-5. PubMed ID: 3365705 [TBL] [Abstract][Full Text] [Related]
10. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse. Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230 [TBL] [Abstract][Full Text] [Related]
11. Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice. Buchegger F; Rojas A; Delaloye AB; Vogel CA; Mirimanoff RO; Coucke P; Sun LQ; Raimondi S; Denekamp J; Pèlgrin A Cancer Res; 1995 Jan; 55(1):83-9. PubMed ID: 7805046 [TBL] [Abstract][Full Text] [Related]
12. Single-Dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using 131I-labeled multivalent CC49 single-chain fvs. Goel A; Augustine S; Baranowska-Kortylewicz J; Colcher D; Booth BJ; Pavlinkova G; Tempero M; Batra SK Clin Cancer Res; 2001 Jan; 7(1):175-84. PubMed ID: 11205906 [TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy with 153Sm-CEA monoclonal antibody in nude mice bearing human colon carcinoma: an experimental study. Li GP; Zhang H; Zhu CM Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):1-5. PubMed ID: 12527502 [TBL] [Abstract][Full Text] [Related]
14. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model. Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357 [TBL] [Abstract][Full Text] [Related]
15. Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections. Kraeber-Bodéré F; Faivre-Chauvet A; Saï-Maurel C; Campion L; Fiche M; Gautherot E; Le Boterff J; Barbet J; Chatal JF; Thédrez P Clin Cancer Res; 1999 Oct; 5(10 Suppl):3183s-3189s. PubMed ID: 10541362 [TBL] [Abstract][Full Text] [Related]
16. Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen. Sharkey RM; Pykett MJ; Siegel JA; Alger EA; Primus FJ; Goldenberg DM Cancer Res; 1987 Nov; 47(21):5672-7. PubMed ID: 3664474 [TBL] [Abstract][Full Text] [Related]
17. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct. Pavlinkova G; Booth BJ; Batra SK; Colcher D Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of a high-affinity anticarcinoembryonic antigen monoclonal antibody (COL-1). Siler K; Eggensperger D; Hand PH; Milenic DE; Miller LS; Houchens DP; Hinkle G; Schlom J Biotechnol Ther; 1993; 4(3-4):163-81. PubMed ID: 8292968 [TBL] [Abstract][Full Text] [Related]